Last updated: October 4, 2023
Sponsor: Boston Sight
Overall Status: Completed
Phase
N/A
Condition
Dermatomyositis (Connective Tissue Disease)
Eyelid Inflammation
Vision Loss
Treatment
Ocular surface optical coherence tomography
Clinical Study ID
NCT04649177
BFS-OCT-01
Ages > 21 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Written Informed Consent has been obtained prior to any study-related procedures
- Male or female, 18 years of age and older prior to the initial visit
- Established wearer of PROSE in the study eye with an optimized fit in the opinion ofthe clinician
- No medical need for a PROSE retreatment or replacement lens at the time of enrollmentin the study eye, in the opinion of the clinician
- Initial PROSE fitting was initiated and completed at BostonSight, Needham
- Current PROSE device does not have channels or fenestrations
- Currently wears a PROSE device in the study eye primarily for an irregular ocularsurface /irregular cornea (including but not limited to Keratoconus, Pellucid MarginalDegeneration, Ectasia, Post-Penetrating Keratoplasty, Corneal Scar, Trauma) AND/ORocular surface disease
- Has the ability to NOT wear the current PROSE device in the study eye for 3 days priorto scan and 3 days prior to first fitting appointment in the opinion of theinvestigator and subject
- In the opinion of the investigator, the subject has the ability to follow studyinstructions
- In the opinion of the investigator, the subject has the ability to complete all studyprocedures and visits
Exclusion
Exclusion Criteria:
- Is currently participating in any other type of eye-related clinical or research study
- Is pregnant or nursing as reported by the subject
- Has a condition or is in a situation which, in the investigator's opinion, may put thesubject at significant risk, may confound study outcomes, or may significantlyinterfere with the subject's participation in the study
- Has had previous ocular surgery within the past 12 weeks
- Intolerance to PROSE wear
- Inability to maintain stable fixation and exposure for ocular surface imaging
- Corneal touch by the posterior surface of the device in current PROSE device
- Allergy to sodium fluorescein
- Patient is an employee of BostonSight
- Subject is currently incarcerated. -
Study Design
Total Participants: 11
Treatment Group(s): 1
Primary Treatment: Ocular surface optical coherence tomography
Phase:
Study Start date:
December 15, 2020
Estimated Completion Date:
March 23, 2022
Study Description
Connect with a study center
BostonSight
Needham, Massachusetts 02494
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.